Aytu Biopharma (AYTU) Net Cash Flow (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Net Cash Flow of -$3.3 million for Q1 2026, down 48.76% year-over-year from -$6.5 million in Q1 2025, and down 27.06% quarter-over-quarter from -$2.6 million in Q4 2025.
Aytu Biopharma (AYTU) Net Cash Flow (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Net Cash Flow for 17 consecutive years, with -$3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 48.76% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at $8.5 million (up 638.25% YoY), while the FY2025 annual figure was $10.9 million, up 467.44% from the prior year.
- Net Cash Flow eased to -$3.3 million in Q1 2026 per AYTU's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $12.8 million in Q2 2025 and bottomed at -$8.3 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$503647.1 across 5 years, with a median of -$328000.0 in 2023.
- On a YoY basis, Net Cash Flow climbed as much as 5094.72% in 2025 and fell as far as 1063.2% in 2025.
- Aytu Biopharma's Net Cash Flow stood at -$4.4 million in 2022, then jumped by 90.02% to -$435000.0 in 2023, then surged by 166.67% to $290000.0 in 2024, then tumbled by 998.28% to -$2.6 million in 2025, then fell by 27.06% to -$3.3 million in 2026.
- Business Quant data shows AYTU's Net Cash Flow at -$3.3 million in Q1 2026, -$2.6 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | -3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.31 Mn |
| Mar 31, 2026 | -3.31 Mn |
| Dec 31, 2025 | -2.61 Mn |
| Dec 31, 2025 | -2.61 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 12.78 Mn |
| Jun 30, 2025 | 12.78 Mn |
| Mar 31, 2025 | -2.23 Mn |
| Mar 31, 2025 | -2.23 Mn |
| Dec 31, 2024 | 290,000.00 |
| Dec 31, 2024 | 290,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 246,000.00 |
| Jun 30, 2024 | 246,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | -435,000.00 |
| Dec 31, 2023 | -435,000.00 |